FOR LIFE SCIENCES AND BIOPHARMA
Real-World Data
Ovation's real-world clinicogenomic data solutions enable life science and biopharma companies to accelerate research and development across a wide range of areas including oncology, cardiology, and infectious disease.
Accelerate preclinical research across therapeutic areas
The application of biomarkers in early-phase clinical development has helped shorten timelines by bringing critical decision points forward. But the traditional method of performing biomarker discovery through clinical trials is still too time-consuming and expensive.
It can take years to recruit, enroll, and sample patients. Even after you’ve finally found results, they’re only capturing a small percentage of the population.
WE ALL AGREE
Patients deserve better.
Ovation is committed to efficiently generating the answers life science and biopharma companies need to advance precision diagnostics and treatments forward with the unique combination of our continually evolving clinicogenomic database and our capabilities for additional research testing on samples from our biorepository.
How it Works
Rapidly and consistently receive the real-world data your research demands, even as the required measurements change throughout a given project.
Not only will we provide your organization with the rare clinicogenomic data required for a desired cohort, but we can also quickly perform additional complex testing through our laboratory network, as needed.
Research & development areas Ovation
is focused on accelerating
FOR LIFE SCIENCES
Biomarker discovery and assay validation
Researchers can quickly and efficiently source genomic data paired with clinical data to investigate novel genomic drivers connected to patient outcomes. Shorten timelines for precision medicine treatments and therapies.
FOR LIFE SCIENCES
Pathogen surveillance
New insights around respiratory infectious disease rely on robust real-world data. Ovation’s database integrates viral genomic data with patient clinical and genomic data to address research questions about viral strains/mutations and their impact on human health.
Genomics is enhancing the diagnosis, treatment, and prevention of many human diseases, but it requires an enormous amount of data that’s time-consuming to collect. With data from Ovation’s lab network, we can accelerate what’s traditionally a multi-year genomic biomarker project into just months.”
Carlos D. Bustamante, PhD
Professor of Biomedical Data Science & Genetics
A clinicogenomic database unlike any other.
Maximize your ability to generate clinically relevant insights with one of the world’s most robust and diverse real-world databases
>90% of records have unique genomic data not found in the commercial marketplace
>99% of records are linkable to the patient journey (data from claims, medical records, and diagnostic tests)
Broad distribution across therapeutic areas, including oncology, infectious disease, cardiology, and more
Reflective of the wider population, including underrepresented groups
Broad Geographic Distribution
Our network of labs deliver genomic data from a diverse set of patients across the country and the globe
Let’s work together to advance science forward
Our team combines the best of the tech and biotech worlds with vast experience managing large clinical and diagnostic data sets. Our clinical affairs specialists, security experts, data scientists, and more work together to deliver data at the highest quality.